WALTHAM, Mass.--(BUSINESS WIRE)--Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced data demonstrating enhanced ...

These are the year's top 10 most-read muscular dystrophy news stories we published last year, each with a brief description.

Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...

Oxford, United Kingdom & Bothell, WA, USA — October 20, 2009 — An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and ...